{
    "Trade/Device Name(s)": [
        "FreeStyle Lite Blood Glucose Test Strips",
        "FreeStyle Lite Blood Glucose Monitoring System",
        "FreeStyle Freedom Lite Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K092602",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070850"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "February 1, 2011",
    "Summary Letter Received Date": "May 10, 2010",
    "Submission Date": "May 8, 2010",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single Analyte Control Solution"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FreeStyle Lite Blood Glucose Monitoring System",
        "FreeStyle Freedom Lite Blood Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric biosensor",
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Test Strip",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle Lite and Freedom Lite Blood Glucose Monitoring Systems and modified Test Strips using coulometric biosensor technology for quantitative glucose measurement.",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary whole blood (finger, upper arm, palm) and venous blood by healthcare professionals and people with diabetes as an aid in monitoring diabetes control; not for diagnosis or screening of diabetes, or for use on neonates or arterial blood.",
    "fda_folder": "Clinical Chemistry"
}